Eikon Therapeutics News and Activities

Eikon Therapeutics is one of the...

• TOB Iconic 10,000;
• Unicorn.

Acquisition, funding and merger involving Eikon Therapeutics.

• Eikon Therapeutics has just announced a $351 Million fundraising (posted on February 27 2025).

View the org chart displaying its 30 main executives

Most searched biographies at Eikon Therapeutics

• Roger Perlmutter, Chief Executive Officer and Director
• Dror Berman, Director
• Kenneth Frazier, Director

Popular executive movements at Eikon Therapeutics

• David Meline has joined the company as Independent Director  (posted on December 3 2025).
• Ashish Kheterpal, Chief Information Officer, has left the company  (posted on September 26 2025).

Create your alert
to follow the executive moves at Eikon Therapeutics.

Eikon Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Eikon Therapeutics

• Eikontx
• Eikontx

Social media about Eikon Therapeutics

• Eikon Therapeutics on Wikipedia, Google News & Yahoo Finance
• Eikon Therapeutics on LinkedIn, X (Twitter) & YouTube